Mpilla, G.; Aboukameel, A.; Muqbil, I.; Kim, S.; Beydoun, R.; Philip, P.A.; Mohammad, R.M.; Kamgar, M.; Shidham, V.; Senapedis, W.;
et al. PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors. Cancers 2019, 11, 1902.
https://doi.org/10.3390/cancers11121902
AMA Style
Mpilla G, Aboukameel A, Muqbil I, Kim S, Beydoun R, Philip PA, Mohammad RM, Kamgar M, Shidham V, Senapedis W,
et al. PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors. Cancers. 2019; 11(12):1902.
https://doi.org/10.3390/cancers11121902
Chicago/Turabian Style
Mpilla, Gabriel, Amro Aboukameel, Irfana Muqbil, Steve Kim, Rafic Beydoun, Philip A. Philip, Ramzi M. Mohammad, Mandana Kamgar, Vinod Shidham, William Senapedis,
and et al. 2019. "PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors" Cancers 11, no. 12: 1902.
https://doi.org/10.3390/cancers11121902
APA Style
Mpilla, G., Aboukameel, A., Muqbil, I., Kim, S., Beydoun, R., Philip, P. A., Mohammad, R. M., Kamgar, M., Shidham, V., Senapedis, W., Baloglu, E., Li, J., Dyson, G., Xue, Y., El-Rayes, B., & Azmi, A. S.
(2019). PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors. Cancers, 11(12), 1902.
https://doi.org/10.3390/cancers11121902